Ituran Location And Control Remains A Buy After Strong Q2 Growth

Ituran (ITRN) reported record Q2 revenue, profitability, and cash flow, with recurring revenue rising to 76% of total. The investment case is supported by valuation at 15.1x forward earnings and 8.7x EV/EBITDA, implying ~27% upside to a $69 fair value if growth and margins persist, alongside OEM partnerships (notably South America) and ongoing capital returns.

Analysis

The market is likely undervaluing the quality of the cash flow stream, but not enough to justify an aggressive rerate yet. A business with a high recurring mix and visible capital return can compound steadily, yet the multiple usually only steps up when investors believe growth is self-funding and durable across cycles. In other words, the setup is more about preventing multiple compression than generating a sudden re-rating, and that means the next 2-3 earnings prints matter more than the current target price.

The main second-order winner is the OEM distribution channel: if it keeps expanding, it lowers customer-acquisition cost and can crowd out smaller aftermarket-only telematics vendors that rely on dealer relationships and higher-touch sales. The structural loser is any local reseller model that depends on manual installs and one-off hardware sales, because recurring revenue plus OEM access generally shifts the economic value to the platform owner. The flip side is that this model also increases concentration risk; a few channel partners or geographies can become the hidden driver of both growth and margin.

The key risk is not demand collapse but normalization: FX moves, Latin America auto-cycle weakness, or a pause in OEM momentum could flatten growth while buybacks merely cushion EPS. The real falsifier is a quarter or two of stagnant recurring revenue contribution, margin giveback, or softer cash conversion — that would keep the stock trapped in value territory despite the headline multiple appearing cheap. Big Data is optionality, not valuation support, unless it becomes a measurable ARPU or retention driver within 6-18 months.

Key Decisions for Investors

• Long ITRN on weakness as a 6-12 month compounder; use the current valuation as a floor only if recurring revenue and cash conversion remain intact. Upside is modest but achievable if the market starts paying for quality instead of just earnings.
• Set a hard watch item on the next 2 quarterly prints: if recurring revenue growth, gross margin, or operating cash flow decelerate, treat the thesis as broken and de-risk immediately. The stock’s multiple has limited room for disappointment.
• If liquidity allows, consider a small ITRN Jan-2027 call spread to express rerating optionality with defined downside; this is cleaner than outright leverage because the thesis depends on proof over multiple quarters, not a single catalyst.
• Relative-value idea: long ITRN versus a basket of lower-quality small-cap growth/telematics exposures if you can source a meaningful pair. The edge is quality of cash flow and shareholder returns, not a high-beta growth story.
• Do not chase on the Big Data narrative alone. Reassess only if management shows a measurable uplift in retention, ARPU, or OEM attach rates within 1-3 quarters; otherwise the option value is likely overstated.